Across TCGA pan-cancer cohorts, EI24P4 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated EI24P4 data layer compared with 19 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher EI24P4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated EI24P4 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.
COAD, LUAD, and BLCA are the cancer types where EI24P4 Mutation most reproducibly stratifies survival.